Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Posch

Showing results (121-130 of 166) with videos related to

Pageof 17
Sort By:
Critical Care Medicine|July 14, 2022
Incidence and Outcomes of Cardiopulmonary Resuscitation in ICUs: Retrospective Cohort AnalysisPaul Zajic, Barbara Hallmann, Gabriel Honnef, et al.
Wiener Klinische Wochenschrift|April 24, 2003
[Optimizing electrotherapy--a comparative study of 3 different currents]Richard Crevenna, Martin Posch, Andrea Sochor, et al.
Eclinicalmedicine|January 16, 2024
Current state-of-the-art and gaps in platform trials: 10 things you should know, insights from EU-PEARLFranz Koenig, Cécile Spiertz, Daniel Millar, et al.
Pharmaceutical Statistics|August 27, 2025
Design Considerations for a Phase II Platform Trial in Major Depressive DisorderMichaela Maria Freitag, Dario Zocholl, Elias Laurin Meyer, et al.
Plos One|January 23, 2023
Association of immediate versus delayed extubation of patients admitted to intensive care units postoperatively and outcomes: A retrospective studyPaul Zajic, Michael Eichinger, Michael Eichlseder, et al.
Scientific Reports|January 9, 2024
Red blood cell transfusion-related dynamics of extracellular vesicles in intensive care patients: a prospective subanalysisPierre Raeven, Katharina Karlhofer, Larissa S Sztulman, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|August 16, 2011
Nanoscalic silver possesses broad-spectrum antimicrobial activities and exhibits fewer toxicological side effects than silver sulfadiazineOliver Brandt, Michael Mildner, Alexander E Egger, et al.
Clinical Pharmacology and Therapeutics|February 5, 2020
Current Statistical Considerations and Regulatory Perspectives on the Planning of Confirmatory Basket, Umbrella, and Platform TrialsOlivier Collignon, Christian Gartner, Anna-Bettina Haidich, et al.
The British Journal of Surgery|December 1, 2021
Growth prediction model for abdominal aortic aneurysmsRobin Ristl, Johannes Klopf, Andreas Scheuba, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 5, 2003
Quality of life in patients with non-metastatic differentiated thyroid cancer under thyroxine supplementation therapyRichard Crevenna, Georg Zettinig, Mohammad Keilani, et al.
Pageof 17

Showing results (121-130 of 166) with videos related to

Sort By:
Pageof 17
Critical Care Medicine|July 14, 2022
Incidence and Outcomes of Cardiopulmonary Resuscitation in ICUs: Retrospective Cohort AnalysisPaul Zajic, Barbara Hallmann, Gabriel Honnef, et al.
Wiener Klinische Wochenschrift|April 24, 2003
[Optimizing electrotherapy--a comparative study of 3 different currents]Richard Crevenna, Martin Posch, Andrea Sochor, et al.
Eclinicalmedicine|January 16, 2024
Current state-of-the-art and gaps in platform trials: 10 things you should know, insights from EU-PEARLFranz Koenig, Cécile Spiertz, Daniel Millar, et al.
Pharmaceutical Statistics|August 27, 2025
Design Considerations for a Phase II Platform Trial in Major Depressive DisorderMichaela Maria Freitag, Dario Zocholl, Elias Laurin Meyer, et al.
Plos One|January 23, 2023
Association of immediate versus delayed extubation of patients admitted to intensive care units postoperatively and outcomes: A retrospective studyPaul Zajic, Michael Eichinger, Michael Eichlseder, et al.
Scientific Reports|January 9, 2024
Red blood cell transfusion-related dynamics of extracellular vesicles in intensive care patients: a prospective subanalysisPierre Raeven, Katharina Karlhofer, Larissa S Sztulman, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|August 16, 2011
Nanoscalic silver possesses broad-spectrum antimicrobial activities and exhibits fewer toxicological side effects than silver sulfadiazineOliver Brandt, Michael Mildner, Alexander E Egger, et al.
Clinical Pharmacology and Therapeutics|February 5, 2020
Current Statistical Considerations and Regulatory Perspectives on the Planning of Confirmatory Basket, Umbrella, and Platform TrialsOlivier Collignon, Christian Gartner, Anna-Bettina Haidich, et al.
The British Journal of Surgery|December 1, 2021
Growth prediction model for abdominal aortic aneurysmsRobin Ristl, Johannes Klopf, Andreas Scheuba, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 5, 2003
Quality of life in patients with non-metastatic differentiated thyroid cancer under thyroxine supplementation therapyRichard Crevenna, Georg Zettinig, Mohammad Keilani, et al.
Pageof 17